# Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

> **NCT02193061** · PHASE3 · COMPLETED · sponsor: **National Institute of Pediatrics, Mexico** · enrollment: 1498 (actual)

## Conditions studied

- Rotavirus Vaccine

## Interventions

- **BIOLOGICAL:** Rotarix
- **BIOLOGICAL:** RotaTeq

## Key facts

- **NCT ID:** NCT02193061
- **Lead sponsor:** National Institute of Pediatrics, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-06
- **Final completion:** 2017-11
- **Target enrollment:** 1498 (ACTUAL)
- **Last updated:** 2018-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193061, "Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02193061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*